ArticleBMC cancer2025
Predictive marker for response to trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer patients.
Toshiaki Takahashi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it